Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06110624
Other study ID # 11265
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date January 1, 2024
Est. completion date April 1, 2024

Study information

Verified date November 2023
Source University Medical Center Groningen
Contact AN KL Reyners, MD, PhD
Phone +31503612821
Email a.k.l.reyners@umcg.nl
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A study on the intent to use a tool (MuSt-PC) to manage symptoms of patients in a palliative care trajectory.


Description:

A survey study will be conducted to evaluate if GHCPs have the Intention to Use (IU) MuSt- PC in daily practice. GHCPs are recruited via the connections of the seven Centers of Expertise in Palliative Care. To invite them to participate in the study, the GHCPs are approached directly via e-mail or telephone. Participating GHCPs will be educated on how to use MuSt-PC (educational materials and instruction webinar). GHCPs will be asked to use the CDSS for five individual patients. Every time after using MuSt-PC they will be asked to answer additional questions about their experience with using MuSt-PC in that specific instance. After using MuSt-PC for five patients, they are requested to fill out a comprehensive questionnaire about their overall experiences with using the CDSS.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 20
Est. completion date April 1, 2024
Est. primary completion date March 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: Residents (in Dutch: Arts In Opleiding tot Specialist (AIOS) or Arts Niet In Opleiding tot Specialist (ANIOS)), medical specialists and nurse practitioners working in the following disciplines are invited to participate: - General practice - Nursing home - Hospital: - Clinical geriatrics - Medical oncology - Radiation oncology - Pulmonology - Cardiology Exclusion Criteria: HCPs who were formally trained in palliative care ("kaderopleiding palliatieve zorg", "Masteropleiding Palliative Medicine for Health Care Professionals at Cardiff University" or "post-HBO opleiding palliatieve zorg") and/or who have been or are currently a consultant of a palliative care consultation team are considered specialists in palliative care, are excluded from participation. GHCPs (e.g. nurses) who cannot independently decide about CDSS recommendation adherence, including drug interventions, are excluded from participation.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Survey
A survey study will be conducted to evaluate if GHCPs have the Intention to Use (IU) MuSt-PC in daily practice.

Locations

Country Name City State
Netherlands University Medical Center Groningen Groningen
Netherlands LUMC Leiden

Sponsors (1)

Lead Sponsor Collaborator
University Medical Center Groningen

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Other A focus group meeting will be conducted if =20% of all participating GHCPs have insufficient intention to use MuSt-PC and/or perceive MuSt-PC insufficiently useful and/or perceive MuSt-PC insufficiently easy to use A focus group meeting will be conducted if =20% of all participating GHCPs have insufficient intention to use MuSt-PC and/or perceive MuSt-PC insufficiently useful and/or perceive MuSt-PC insufficiently easy to use:
Insufficient IU is defined as a sum score of =12 for the 3 questions that measure Intention to Use by the modified TAM questionnaire (maximum sum score 21)
Insufficient PU is defined as a sum score of =24 for the 6 questions that measure PU by the modified TAM questionnaire (maximum sum score 42)
insufficient PEU is defined as a sum score of =24 for the 6 items that measure PEU by the modified TAM questionnaire (maximum sum score 42). (see Appendix G) Six to twelve GHCPs with a sum score of =12 (IU) and/or =24 (PU and/or PEU) will be invited to participate.
after 5 times use of the MuSt-PC tool within 3 months
Primary Questions evaluating Intention to Use (IU) Questions evaluating Intention to Use (IU) (7-point Likert scales) after 5 times use of the MuSt-PC tool within 3 months
Secondary Questions evaluating other modified TAM domains Questions evaluating other modified TAM domains: Perceived Usefulness, Perceived Ease-of-Use, Attitude, Compatibility, Subjective norm, Facilitators, Habit (7-point Likert Scales). after 5 times use of the MuSt-PC tool within 3 months
Secondary Perceived benefits and disadvantages of using MuSt-PC Perceived benefits and disadvantages of using MuSt-PC (open-ended questions). after 5 times use within 3 months
Secondary Suggestions to improve the MuSt-PC CDSS Suggestions to improve the MuSt-PC CDSS (open-ended question). after 5 times of the MuSt-PC tool within 3 months
Secondary An overview of the content of questions of participating GHCPs regarding MuSt-PC use. An overview of the content of questions of participating GHCPs regarding MuSt-PC use. Questions will be analyzed qualitatively; coding will be done independently by two researchers. In case of disagreement, consensus will be achieved through discussion. Coding will result in categorization of question subject. Categorizations are ranked from most prevalent to least prevalent question subject (proportion of respondents). after 5 times use within 3 months
Secondary Most useful elements of MuSt-PC will be evaluated with a multiple-choice question. Most useful elements of MuSt-PC will be evaluated with a multiple-choice question. (multiple answers allowed) Frequency and percentage of total respondents who chose the multiple choice answer possibilities will be evaluated after 5 times use within 3 months
Secondary Mean scores of HCPs adherence to CDSS recommendations Mean scores (5-point Likert scale) of HCPs adherence to CDSS recommendations (each time using MuSt-PC) after 5 times use of the MuSt-PC tool within 3 months
See also
  Status Clinical Trial Phase
Completed NCT03665168 - A Multidimensional Strategy to Improve Quality of Life of Patients With Multiple Symptoms and Palliative Care Needs
Withdrawn NCT03245658 - The Effect of Cannabis in Pancreatic Cancer Phase 2
Not yet recruiting NCT06328751 - Meditation With Virtual Reality for Cancer Pain Relief in the Pain Therapy and Palliative Care Service N/A
Recruiting NCT05883696 - Palliative Care Needs Among Elderly People at Emergency Department
Completed NCT01415934 - Statin Discontinuation in Advanced Illness N/A
Recruiting NCT04519632 - Paediatric Palliative Care Pain Management in the Community
Completed NCT04630743 - Cognitive and Behavioral Intervention for the Management of Episodic Breathlessness in Patients With Advanced Disease N/A
Completed NCT05454644 - Effectiveness of a Person-centred Prescription Model at the End of Life N/A
Not yet recruiting NCT06329856 - Exploring Indications and Practices of Administering Artificial Hydration to Terminal Cancer Patients in Taiwan
Terminated NCT02581059 - Efficacy of Ginseng for Patients on Regorafenib Phase 2
Terminated NCT04251520 - The Role of the Pharmacist and Pharmacogenomics in the Care of Seriously Ill Patients N/A
Withdrawn NCT06310889 - Evaluation of Palliative Care Co-treatment by Attending Physicians and Nurses: an Online Survey as Part of the Project
Completed NCT05640076 - Effects of a 24/7 Palliative Care Service Integration in a Metropolitan Area on Non-oncologic Patients